240 related articles for article (PubMed ID: 34702779)
1. Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care.
Iyen B; Akyea RK; Weng S; Kai J; Qureshi N
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34702779
[TBL] [Abstract][Full Text] [Related]
2. The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia.
Lalić K; Rajković N; Popović L; Lukač SS; Stošić L; Rasulić I; Lalić NM
Atherosclerosis; 2018 Oct; 277():298-303. PubMed ID: 30270062
[TBL] [Abstract][Full Text] [Related]
3. The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data.
Ramaswami U; Cooper J; Humphries SE;
Arch Dis Child; 2017 Mar; 102(3):255-260. PubMed ID: 26948823
[TBL] [Abstract][Full Text] [Related]
4. Patterns of statin use and cholesterol goal attainment in a high-risk cardiovascular population: A retrospective study of primary care electronic medical records.
García-Gil M; Blanch J; Comas-Cufí M; Daunis-i-Estadella J; Bolíbar B; Martí R; Ponjoan A; Alves-Cabratosa L; Ramos R
J Clin Lipidol; 2016; 10(1):134-42. PubMed ID: 26892130
[TBL] [Abstract][Full Text] [Related]
5. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.
Vrablik M; Raslová K; Vohnout B; Blaha V; Satny M; Kyselak O; Vaclova M; Urbanek R; Maskova J; Soska V; Freiberger T
Atherosclerosis; 2018 Oct; 277():355-361. PubMed ID: 30270071
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries.
Ramaswami U; Futema M; Bogsrud MP; Holven KB; Roeters van Lennep J; Wiegman A; Descamps OS; Vrablik M; Freiberger T; Dieplinger H; Greber-Platzer S; Hanauer-Mader G; Bourbon M; Drogari E; Humphries SE
Atherosclerosis; 2020 Jan; 292():178-187. PubMed ID: 31809987
[TBL] [Abstract][Full Text] [Related]
7. Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.
Saltijeral A; Pérez de Isla L; Alonso R; Muñiz O; Díaz-Díaz JL; Fuentes F; Mata N; de Andrés R; Díaz-Soto G; Pastor J; Pinilla JM; Zambón D; Pinto X; Badimón L; Mata P;
Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):444-450. PubMed ID: 27913073
[TBL] [Abstract][Full Text] [Related]
8. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
[TBL] [Abstract][Full Text] [Related]
9. The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data.
Humphries SE; Cooper J; Dale P; Ramaswami U;
J Clin Lipidol; 2018; 12(1):25-32. PubMed ID: 29208363
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).
Bucholz EM; Rodday AM; Kolor K; Khoury MJ; de Ferranti SD
Circulation; 2018 May; 137(21):2218-2230. PubMed ID: 29581125
[TBL] [Abstract][Full Text] [Related]
12. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
[TBL] [Abstract][Full Text] [Related]
13. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice.
Vohnout B; Fábryová Ľ; Klabník A; Kadurová M; Bálinth K; Kozárová M; Bugáňová I; Sirotiaková J; Rašlová K
Atherosclerosis; 2018 Oct; 277():323-326. PubMed ID: 30270066
[TBL] [Abstract][Full Text] [Related]
14. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies.
Knickelbine T; Lui M; Garberich R; Miedema MD; Strauss C; VanWormer JJ
J Clin Lipidol; 2016; 10(5):1182-7. PubMed ID: 27678435
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study.
Blom DJ; Almahmeed W; Al-Rasadi K; Azuri J; Daclin V; Kayikcioglu M; Mercier F; Ruiz AJ; Santos RD;
J Clin Lipidol; 2019; 13(4):594-600. PubMed ID: 31208705
[TBL] [Abstract][Full Text] [Related]
17. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
[TBL] [Abstract][Full Text] [Related]
18. Lipid management and cholesterol goal attainment in Norway.
Ose L; Skjeldestad FE; Bakken IJ; Levorsen A; Alemao EA; Yin DD; Borgström F; Jönsson L
Am J Cardiovasc Drugs; 2006; 6(2):121-8. PubMed ID: 16555865
[TBL] [Abstract][Full Text] [Related]
19. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
[TBL] [Abstract][Full Text] [Related]
20. Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan.
Teramoto T; Kai T; Ozaki A; Crawford B; Arai H; Yamashita S
J Atheroscler Thromb; 2018 Jul; 25(7):580-592. PubMed ID: 29353825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
